Stock code: 002653.SZ
News
Business News
Xinhua Net: Haisco Technology Steps into the Top Tier of Innovation
Jun 26, 2026
Learn more
Xinhua Net: Class 1 innovative drug Youkepan is approved for Phase 7 of Nanjing’s “Ninghui Bao”, accelerating benefits for PNH patients
2026-09-24
Learn more
Haisco Co. launches the 2026 China Fair Competition Policy Promotion Week activity
2026-09-11
Learn more
One picture to understand | Haisco Co. releases 2026 semi-annual performance report
2026-08-27
Learn more
Haisco's independently developed pre-clinical autoimmune innovation drug has received an exclusive overseas license, with potential value exceeding $1.5 billion.
2026-08-26
Learn more
The new indication for the innovative drug HSK47388 tablets (I) has been approved, which is psoriatic arthritis.
2026-08-19
Learn more
Chinese Doctors' Day | Pay tribute to compassionate doctors
2026-08-19
Learn more
Xinhua News Agency’s “Half-Month Talk” focuses on Haisco’s innovative drugs’ moment on the market
2026-08-14
Learn more
The clinical trial of the innovative drug HSK60002 tablets has been approved for the treatment of inflammatory diseases.
2026-08-13
Learn more
At 8 p.m. last night, Haisco was featured on national television.
2026-08-05
Learn more
Haisco Group's Official WeChat Account
Haisco Investor Relations WeChat Account
Haisco Raw Materials Procurement Inquiries